Trials / Completed
CompletedNCT00657761
Metabolic Effects of Enfuvirtide in Healthy Volunteers
Effect of Enfuvirtide on Lipid and Glucose Metabolism and Mitochondrial Function in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Hospital Clinic of Barcelona · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The metabolic effects of T-20 are not completely known, since the drug is used in combination with other antiretroviral agents. A short-term study in healthy volunteers, with a double-blind crossover design vs. placebo will illustrate if there may be some direct metabolic effects without the influence of HIV infection and the concurrent use of other drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enfuvirtide | 90 mg/12h sc for 7 days |
| DRUG | Placebo | 0.9% saline solution/12h sc for 7 days |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2006-03-01
- Completion
- 2006-03-01
- First posted
- 2008-04-14
- Last updated
- 2008-04-14
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00657761. Inclusion in this directory is not an endorsement.